Kenacort-A 40, suspensie voor injectie 40 mg/ml, Jyseleca 200 mg film-coated tablets
2024-517112-30-00
Approved small_molecule active
Quick answer
Kenacort-A 40, suspensie voor injectie 40 mg/ml, Jyseleca 200 mg film-coated tablets for Rheumatoid arthritis is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Rheumatoid arthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active